Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of
MECP2
Deficiency and Is a Potential Therapy for Rett Syndrome
Epilepsy Curr
.
2020 Sep 30;20(6):390-392.
doi: 10.1177/1535759720960469.
eCollection 2020 Nov-Dec.
Authors
Kay-Marie Joan Lamar
1
,
Gemma L Carvill
1
Affiliation
1
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
PMID:
34025262
PMCID:
PMC7818197
DOI:
10.1177/1535759720960469
No abstract available
Publication types
Comment
Grants and funding
F32 HD101280/HD/NICHD NIH HHS/United States